Home > Boards > US Listed > Medical - Equipment > Obalon Therapeutics, Inc. (OBLN)

SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) --

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
r clarke Member Profile
 
Followed By 13
Posts 3,095
Boards Moderated 0
Alias Born 11/16/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 3/30/2020 4:37:15 PM
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives GlobeNewswire Inc. - 3/25/2020 8:30:10 AM
Obalon Temporarily Suspends New Patient Sales at Its Retail Treatment Centers Due to Coronavirus Pandemic GlobeNewswire Inc. - 3/17/2020 5:21:32 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/2/2020 6:01:18 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 2/28/2020 5:14:57 PM
Annual Report (10-k) Edgar (US Regulatory) - 2/27/2020 8:54:28 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2020 7:31:19 AM
Obalon Announces Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire Inc. - 2/27/2020 7:31:10 AM
Obalon Announces Opening of Second Retail Treatment Center in Orange County, CA GlobeNewswire Inc. - 2/20/2020 8:15:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:06:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 7:03:35 AM
Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Easter... GlobeNewswire Inc. - 2/13/2020 9:00:10 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 2/7/2020 4:34:38 PM
Obalon Enters into New Stock Purchase Agreement with Lincoln Park Capital Fund GlobeNewswire Inc. - 2/7/2020 4:15:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2020 4:08:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 4:31:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 4:31:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 4:31:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 4:31:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/28/2020 4:31:15 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 1/24/2020 4:12:03 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/23/2020 3:09:53 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 1/10/2020 4:05:56 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/9/2020 4:49:42 PM
Obalon Enters into a Distribution Agreement for Qatar GlobeNewswire Inc. - 12/18/2019 8:30:10 AM
r clarke   Tuesday, 03/05/19 09:38:42 PM
Re: None
Post # of 523 
SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announces the first commercial use of the Obalon Navigation System™ and Touch™ Inflation Dispenser for balloon administration. The Obalon Navigation System and Touch Inflation Dispenser are intended to improve the reliability and ease of balloon administration, and to reduce the costs and logistics for physicians to adopt the Obalon Balloon System as a non-surgical treatment for their patients with obesity.

Dr. Shawn Garber of New York Bariatric Group, who performed the first commercial administration using the Obalon Navigation System said, “We have made the Obalon Balloon a standard of care in my practice with outstanding outcomes for patients. The new Obalon Navigation System, which eliminates the need for x-ray, improves the ease of use and will allow us to now more easily and economically treat patients with systems at multiple sites.”

Kelly Huang, PhD, CEO of Obalon added, “We believe the Obalon Navigation System addresses the largest barrier for physician adoption and will allow us to further penetrate the significant potential market for patients with obesity. We remain dedicated to helping obese adults with a body mass index (BMI) of between 30 and 40 kg/m2 achieve effective weight loss to improve their health and increase their self-esteem.”

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist